20/20 Biolabs Statistics
NASDAQ: AIDXHealth CarePrecision InstrumentsUSD
0.3435-0.009 (-2.55%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
20/20 Biolabs by the numbers
20/20 Biolabs has a market capitalization of $4.4 million based on 12.77M shares outstanding. With trailing EPS of $-0.75, 20/20 Biolabs is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.2% below its 50-day average and 76.7% below its 200-day average.
Average daily trading volume is 91.83K shares, or about $31,545 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
Valuation
- Market cap
- $4.39M
- EPS (TTM)
- $-0.75
- Shares outstanding
- 12.77M
Price and trading
- Previous close
- 0.3525
- Open
- 0.359
- Day range
- 0.342 – 0.3594
- 52-week range
- 0.33 – 50.00
- 50-day moving average
- 0.4918
- Beta
- —
- Volume
- 75.12K
- Average volume
- 91.83K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 4.39M
- Eps
- -0.75
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 50.00
- Week52 Low
- 0.33
- Avg Volume
- 91,833.00
- Shares Outstanding
- 12.77M
- Ma50
- 0.49
- Ma200
- 1.48
- Pct From52w High
- -99.31%
- Pct From52w Low
- 4.09%